S3845 – Genetic testing for alpha-thalassemia

Long description

Genetic testing for alpha-thalassemia

Short description

Gene test alpha-thalassemia

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

I Not payable by Medicare

BETOS category

Z2 Undefined codes

Added

July 1, 2003

Last change

July 1, 2003 – No change

Nearby S codes

• S3708 – Gastrointestinal fat absorption study
• S3721 – Prostate cancer antigen 3 (pca3) testing
• S3722 – Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
• S3800 – Genetic testing for amyotrophic lateral sclerosis (als)
• S3840 – Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
• S3841 – Genetic testing for retinoblastoma
• S3842 – Genetic testing for von hippel-lindau disease
• S3844 – Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
• S3846 – Genetic testing for hemoglobin e beta-thalassemia
• S3849 – Genetic testing for niemann-pick disease
• S3850 – Genetic testing for sickle cell anemia
• S3852 – Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
• S3853 – Genetic testing for myotonic muscular dystrophy
• S3854 – Gene expression profiling panel for use in the management of breast cancer treatment
• S3855 – Genetic testing for detection of mutations in the presenilin - 1 gene
• S3861 – Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome